YI
111, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$2.98
+0.34%Margins
Gross margin
5.7%
EBITDA margin
-0.3%
EBIT margin
-0.5%
Net margin
-0.9%
FCF margin
-0.4%
83.1%
Return on equity
-5.3%
Return on assets
-29.9%
Return on invested capital
10.09x
Asset turnover
-$5.3M
Cash from operations
$6.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026